BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30235249)

  • 1. Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure.
    Vanninen SUM; Leivo K; Seppälä EH; Aalto-Setälä K; Pitkänen O; Suursalmi P; Annala AP; Anttila I; Alastalo TP; Myllykangas S; Heliö TM; Koskenvuo JW
    PLoS One; 2018; 13(9):e0203422. PubMed ID: 30235249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity.
    Valtonen J; Prajapati C; Cherian RM; Vanninen S; Ojala M; Leivo K; Heliö T; Koskenvuo J; Aalto-Setälä K
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans.
    Landstrom AP; Weisleder N; Batalden KB; Bos JM; Tester DJ; Ommen SR; Wehrens XH; Claycomb WC; Ko JK; Hwang M; Pan Z; Ma J; Ackerman MJ
    J Mol Cell Cardiol; 2007 Jun; 42(6):1026-35. PubMed ID: 17509612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of enriched rare variants in JPH2-encoded junctophilin-2 among Greater Middle Eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy.
    Jones EG; Mazaheri N; Maroofian R; Zamani M; Seifi T; Sedaghat A; Shariati G; Jamshidi Y; Allen HD; Wehrens XHT; Galehdari H; Landstrom AP
    Sci Rep; 2019 Jun; 9(1):9038. PubMed ID: 31227780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
    Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
    J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel junctophilin-2 mutation A405S is associated with basal septal hypertrophy and diastolic dysfunction.
    Quick AP; Landstrom AP; Wang Q; Beavers DL; Reynolds JO; Barreto-Torres G; Tran V; Showell J; Philippen LE; Morris SA; Skapura D; Bos JM; Pedersen SE; Pautler RG; Ackerman MJ; Wehrens XH
    JACC Basic Transl Sci; 2017 Feb; 2(1):56-67. PubMed ID: 28393127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing.
    Zhao Y; Feng Y; Ding X; Dong S; Zhang H; Ding J; Xia X
    Int J Mol Med; 2017 Jul; 40(1):121-129. PubMed ID: 28498465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One gene, two modes of inheritance, four diseases: A systematic review of the cardiac manifestation of pathogenic variants in JPH2-encoded junctophilin-2.
    Parker LE; Kramer RJ; Kaplan S; Landstrom AP
    Trends Cardiovasc Med; 2023 Jan; 33(1):1-10. PubMed ID: 34861382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study.
    Girolami F; Iascone M; Tomberli B; Bardi S; Benelli M; Marseglia G; Pescucci C; Pezzoli L; Sana ME; Basso C; Marziliano N; Merlini PA; Fornaro A; Cecchi F; Torricelli F; Olivotto I
    Circ Cardiovasc Genet; 2014 Dec; 7(6):741-50. PubMed ID: 25173926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals.
    Salazar-Mendiguchía J; Barriales-Villa R; Lopes LR; Ochoa JP; Rodríguez-Vilela A; Palomino-Doza J; Larrañaga-Moreira JM; Cicerchia M; Cárdenas-Reyes I; García-Giustiniani D; Brögger N; Fernández G; García S; Santiago L; Vélez P; Ortiz-Genga M; Elliott PM; Monserrat L
    Eur J Med Genet; 2020 Dec; 63(12):104079. PubMed ID: 33035702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
    Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
    Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.
    Yang JH; Zheng DD; Dong NZ; Yang XJ; Song JP; Jiang TB; Cheng XJ; Li HX; Zhou BY; Zhao CM; Jiang WP
    Chin Med J (Engl); 2006 Nov; 119(21):1785-9. PubMed ID: 17097032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYH7 Gene-Related Mutation p.V878L Identified in a Chinese Family with Hypertrophic Cardiomyopathy.
    Du Y; Wang Y; Han X; Feng Z; Ma A
    Int Heart J; 2019 Nov; 60(6):1415-1420. PubMed ID: 31735781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy.
    Bottillo I; D'Angelantonio D; Caputo V; Paiardini A; Lipari M; De Bernardo C; Giannarelli D; Pizzuti A; Majore S; Castori M; Zachara E; Re F; Grammatico P
    Gene; 2016 Feb; 577(2):227-35. PubMed ID: 26656175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy.
    Matsushita Y; Furukawa T; Kasanuki H; Nishibatake M; Kurihara Y; Ikeda A; Kamatani N; Takeshima H; Matsuoka R
    J Hum Genet; 2007; 52(6):543-548. PubMed ID: 17476457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.
    Meyer T; Pankuweit S; Richter A; Maisch B; Ruppert V
    Gene; 2013 Sep; 527(1):416-20. PubMed ID: 23816408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management.
    Baxi AJ; Restrepo CS; Vargas D; Marmol-Velez A; Ocazionez D; Murillo H
    Radiographics; 2016; 36(2):335-54. PubMed ID: 26963450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.